It can decrease the maturation of dendritic cells (DCs) by promoting the production of vascular endothelial growth factor (VEGF) (Lin et al., 2004; Zhang et al., 2005), and it can also regulate tumor cell energy metabolism programs and regulate cell cycle checkpoint proteins (Semenza, 2012b; Hu et al., 2019). This evidence concerns the gene VEGFA and neoplasm.